Skip to main content

Peer Review reports

From: Are anti-PD-1-associated immune related adverse events a harbinger of favorable clinical prognosis in patients with gastric cancer?

Original Submission
19 May 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
26 Jun 2022 Reviewed Reviewer Report
5 Sep 2022 Reviewed Reviewer Report
10 Sep 2022 Author responded Author comments - Zhanjun Guo
Resubmission - Version 3
10 Sep 2022 Submitted Manuscript version 3
21 Sep 2022 Author responded Author comments - Zhanjun Guo
Resubmission - Version 4
21 Sep 2022 Submitted Manuscript version 4
5 Oct 2022 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
19 Oct 2022 Editorially accepted
5 Nov 2022 Article published 10.1186/s12885-022-10199-x

You can find further information about peer review here.

Back to article page